SiBone (SIBN) Competitors $16.62 -0.11 (-0.66%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$16.63 +0.01 (+0.06%) As of 07/18/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SIBN vs. WRBY, LIVN, EYE, NVCR, LMAT, ENOV, CNMD, CDRE, AORT, and ESTAShould you be buying SiBone stock or one of its competitors? The main competitors of SiBone include Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), NovoCure (NVCR), LeMaitre Vascular (LMAT), Enovis (ENOV), CONMED (CNMD), Cadre (CDRE), Artivion (AORT), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry. SiBone vs. Its Competitors Warby Parker LivaNova National Vision NovoCure LeMaitre Vascular Enovis CONMED Cadre Artivion Establishment Labs Warby Parker (NYSE:WRBY) and SiBone (NASDAQ:SIBN) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Which has better earnings and valuation, WRBY or SIBN? Warby Parker has higher revenue and earnings than SiBone. Warby Parker is trading at a lower price-to-earnings ratio than SiBone, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$771.32M3.24-$20.39M-$0.12-199.33SiBone$167.18M4.24-$30.91M-$0.64-25.97 Is WRBY or SIBN more profitable? Warby Parker has a net margin of -1.79% compared to SiBone's net margin of -15.03%. Warby Parker's return on equity of -2.48% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-1.79% -2.48% -1.29% SiBone -15.03%-16.00%-11.69% Which has more risk & volatility, WRBY or SIBN? Warby Parker has a beta of 2.09, suggesting that its share price is 109% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Do insiders and institutionals hold more shares of WRBY or SIBN? 93.2% of Warby Parker shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 18.2% of Warby Parker shares are held by company insiders. Comparatively, 3.9% of SiBone shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer WRBY or SIBN? Warby Parker presently has a consensus target price of $22.88, suggesting a potential downside of 4.37%. SiBone has a consensus target price of $22.50, suggesting a potential upside of 35.38%. Given SiBone's stronger consensus rating and higher possible upside, analysts clearly believe SiBone is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 9 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.53SiBone 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor WRBY or SIBN? In the previous week, Warby Parker had 8 more articles in the media than SiBone. MarketBeat recorded 9 mentions for Warby Parker and 1 mentions for SiBone. Warby Parker's average media sentiment score of 0.52 beat SiBone's score of 0.37 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryWarby Parker beats SiBone on 11 of the 16 factors compared between the two stocks. Get SiBone News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIBN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIBN vs. The Competition Export to ExcelMetricSiBoneMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$708.25M$6.65B$5.53B$9.41BDividend YieldN/A1.33%4.00%4.04%P/E Ratio-25.9725.6528.2519.76Price / Sales4.2462.29412.5889.28Price / CashN/A20.4724.9928.17Price / Book4.184.618.095.69Net Income-$30.91M$176.14M$3.25B$257.97M7 Day Performance-3.37%0.40%1.63%3.74%1 Month Performance1.40%2.96%7.62%11.95%1 Year Performance0.06%3.10%32.74%19.22% SiBone Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSiBone3.839 of 5 stars$16.62-0.7%$22.50+35.4%+0.1%$708.25M$167.18M-25.97350WRBYWarby Parker2.6142 of 5 stars$23.02+3.7%$22.88-0.6%+51.5%$2.41B$795.09M-191.803,780News CoverageLIVNLivaNova3.3467 of 5 stars$43.97-0.8%$59.29+34.8%-20.7%$2.40B$1.25B-10.752,900News CoveragePositive NewsEYENational Vision2.927 of 5 stars$25.01+2.2%$22.10-11.6%+91.4%$1.98B$1.82B-75.7913,411News CoverageNVCRNovoCure3.6856 of 5 stars$17.42-1.0%$32.43+86.2%-12.9%$1.94B$605.22M-11.541,488News CoverageUpcoming EarningsGap UpLMATLeMaitre Vascular2.7261 of 5 stars$84.09+0.5%$97.83+16.3%-7.5%$1.90B$226.26M42.47490News CoveragePositive NewsENOVEnovis2.9163 of 5 stars$31.91-6.2%$55.60+74.3%-43.7%$1.82B$2.15B-2.297,367News CoverageCNMDCONMED4.7813 of 5 stars$50.04-2.4%$62.20+24.3%-33.0%$1.55B$1.31B13.173,900News CoverageCDRECadre3.3072 of 5 stars$33.47+2.1%$37.50+12.0%-13.3%$1.36B$567.56M35.232,284AORTArtivion2.0514 of 5 stars$31.68+0.7%$32.40+2.3%+11.9%$1.35B$390.08M-63.361,600ESTAEstablishment Labs2.3947 of 5 stars$45.53+1.4%$51.80+13.8%-8.6%$1.32B$166.02M-14.691,018Analyst Forecast Related Companies and Tools Related Companies Warby Parker Competitors LivaNova Competitors National Vision Competitors NovoCure Competitors LeMaitre Vascular Competitors Enovis Competitors CONMED Competitors Cadre Competitors Artivion Competitors Establishment Labs Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIBN) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SiBone Please log in to your account or sign up in order to add this asset to your watchlist. Share SiBone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIBN Stock Alerts